Treatment of Acne Vulgaris Using NAFL in Combination With Isotretinoin and Pricking Blood Therapy
Status:
Completed
Trial end date:
2018-10-05
Target enrollment:
Participant gender:
Summary
BACKGROUND Isotretinoin remains one of the first line medications for moderate-to-severe acne
vulgaris (AV) but its side effect is a major concern for Asian patients.
OBJECTIVE Investigators aimed to evaluate the efficacy and safety of the 1,565 nm
non-ablative fractional laser (NAFL) in combination with isotretinoin and pricking blood
therapy (PBT) for treatment of AV.
METHODS A retrospective analysis of 60 patients with moderate-to-severe AV was performed.
Four groups (n=15) were evaluated: 1,565nm NAFL alone, oral isotretinoin alone, double
therapy (NAFL + isotretinoin) and triple therapy (NAFL + isotretinoin + PBT).